AcariaHealth Highlights National Biosimilars Education Efforts with Three Events

Rhea-AI Summary

AcariaHealth (NYSE:CNC) completed three national educational events in October focused on the U.S. biosimilars landscape.

Collaborations with the National Association of Specialty Pharmacy, Reuters Events, and an AcariaHealth webinar delivered practical guidance on biosimilar adoption, patient access, and specialty pharmacy readiness. Sessions covered regulatory and market updates, communication tactics to reduce provider and patient hesitancy, substitution rules, payer dynamics, and workflow optimization. On‑demand recordings of all three programs are available.

News Market Reaction

-3.12%

1 alert

-3.12% News Effect

On the day this news was published, CNC declined 3.12%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Sessions with AcariaHealth, the National Association of Specialty Pharmacy (NASP), and Reuters Events deliver actionable insights on biosimilar adoption, patient access, and specialty pharmacy readiness  

ORLANDO, Fla., Nov. 20, 2025 /PRNewswire/ -- AcariaHealth, a leading specialty pharmacy and a company of Centene Corporation (NYSE: CNC), announced the completion of three national educational events in October focused on the evolving U.S. biosimilars landscape. Hosted in collaboration with NASP, Reuters Events, and through an AcariaHealth-led webinar, the sessions provided healthcare professionals with actionable, real-world guidance to support biosimilar utilization, reduce access barriers, and improve patient outcomes. On-demand recordings of all three programs are now available. 

"AcariaHealth is committed to equipping healthcare professionals with the knowledge and tools needed to confidently integrate biosimilars into patient care," said Jessica Ciccolella-Kahl, CEO of AcariaHealth. "Education is essential to improving access and ensuring patients benefit from safe, effective, and affordable therapies." 

NASP Lunch & Learn: "Biosimilars Unveiled: Strategies for Success in Specialty Pharmacy" 
Speaker: Kathleen Stenberg, PharmD, CSP, Lead Specialty Pharmacist, AcariaHealth 

This session delivered foundational biosimilar education, addressed common questions from providers and patients, and outlined strategies for overcoming substitution and workflow challenges within specialty pharmacy. 

Watch the recording: NASP Lunch & Learn Replay

Reuters Events Panel: "Biosimilars in U.S. Healthcare: Adoption, Opportunities, and Outcomes" 
Panelist: Kathleen Stenberg, PharmD, CSP, Lead Specialty Pharmacist, AcariaHealth 

Industry leaders shared perspectives on biosimilar adoption trends, policy considerations, and access challenges. Dr. Stenberg offered specialty-pharmacy insights focused on patient care, payer expectations, and operational readiness for biosimilars. 

Watch the recording: Reuters Events Replay 

AcariaHealth Webinar: "Biosimilars in Practice: Maintaining Access and Prioritizing Patient Care" 
Speakers: 

• Alysha Robinson, PharmD, CSP — Director, Specialty Pharmacy Program Management
• Kathleen Stenberg, PharmD, CSP — Lead Specialty Pharmacist
• Robin Waida — Director, Physician Sales

The AcariaHealth-hosted webinar covered biosimilar fundamentals, addressed common misconceptions, and explored both patient and provider hesitancy. Presenters also shared actionable strategies for supporting successful biosimilar integration across care settings. 

Watch the recording: AcariaHealth Webinar Replay 

Key Insights Across All Sessions 

• Current regulatory and market updates shaping biosimilar adoption 

• Communication approaches to reduce provider and patient hesitancy 

• System-level considerations, including substitution rules, payer dynamics, and workflow optimization  

About AcariaHealth 

AcariaHealth is a national specialty pharmacy dedicated to supporting patients with complex conditions through personalized care and clinical expertise. As a Centene company, AcariaHealth leverages the strength of the largest Medicaid managed care organization to deliver transformative outcomes across the country. 

Learn more: AcariaHealth.com 
Follow us on LinkedIn 

View original content to download multimedia:https://www.prnewswire.com/news-releases/acariahealth-highlights-national-biosimilars-education-efforts-with-three-events-302622247.html

SOURCE AcariaHealth

FAQ

What did AcariaHealth announce about biosimilars on November 20, 2025 (CNC)?

AcariaHealth announced it completed three October events on biosimilars education and made on‑demand recordings available.

Which organizations partnered with AcariaHealth for the biosimilars events (CNC)?

AcariaHealth partnered with the National Association of Specialty Pharmacy and Reuters Events and hosted an AcariaHealth webinar.

What topics did the AcariaHealth (CNC) sessions cover for specialty pharmacy?

Sessions covered regulatory and market updates, substitution rules, payer dynamics, workflow optimization, and communication to reduce hesitancy.

Who represented AcariaHealth on the Reuters Events panel about biosimilars (CNC)?

Kathleen Stenberg, PharmD, CSP, Lead Specialty Pharmacist at AcariaHealth, served as a panelist.

How can healthcare professionals access the AcariaHealth biosimilars recordings (CNC)?

On‑demand recordings for the NASP Lunch & Learn, Reuters Events panel, and AcariaHealth webinar are available for viewing.

What practical benefits did AcariaHealth say the events provide to clinicians (CNC)?

The events aimed to provide actionable, real‑world guidance to support biosimilar use, reduce access barriers, and improve patient outcomes.